Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/20/2025 6:04:49 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 4592
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
48086
Breakthrough Therapy Designation Year 2018 as of
(1)
lousy.engineer
08/27/2018 6:34:33 PM
48085
I think this is a fair refutation of your "honest
(3)
B.Izzy
08/27/2018 6:34:27 PM
48084
I think this is a fair refutation of your "honest
(6)
B.Izzy
08/27/2018 6:34:07 PM
48083
Friends of cancer blah blah..Is that a government
scottyincuffs
08/27/2018 6:19:57 PM
48082
Why? Please refute intelligently. This is for all
lousy.engineer
08/27/2018 5:55:45 PM
48081
Yup bashing as well....
scottyincuffs
08/27/2018 5:54:46 PM
48080
First thing to note is Galera has not even
(1)
lousy.engineer
08/27/2018 5:52:17 PM
48079
portfolio of mere Phase 2 drugs? How about a
(2)
scottyincuffs
08/27/2018 5:32:52 PM
48078
Yes, it was stopped abruptly. If it wasn't
(2)
lousy.engineer
08/27/2018 5:32:36 PM
48077
they (NR) *imo* barely did 10 day volume
(4)
4kids
08/27/2018 5:27:31 PM
48076
And here we go with the return of soft bashing.
(3)
Drano
08/27/2018 4:46:26 PM
48075
Had my finger on the trigger for some bonus
Squar
08/27/2018 4:27:13 PM
48074
It's being realistic rather than drinking
(6)
lousy.engineer
08/27/2018 4:25:29 PM
48073
Added 5000 shares near close.
(1)
Trading Pro Broker
08/27/2018 4:04:52 PM
48072
Boo- I know for me with my # of shares, I found
(2)
Mabuhay
08/27/2018 2:28:45 PM
48071
IMO - we can see PR and 8k before the
(1)
Mabuhay
08/27/2018 2:23:23 PM
48070
Yes and that way we can all give the SS's of the
(5)
Kelt
08/27/2018 1:41:17 PM
48069
Five weeks and counting. Such good things are
(3)
Squar
08/27/2018 1:40:16 PM
48068
Could very well be life changing for some. Not
(1)
BooDog
08/27/2018 1:22:35 PM
48067
Well I am going to stick my neck out and make a
(2)
AlanC
08/27/2018 1:21:25 PM
48066
I have been impressed with the staunch support
(5)
petemantx
08/27/2018 1:11:29 PM
48065
Yep, people are just holding on, waiting for the
(1)
Drano
08/27/2018 12:56:42 PM
48064
August 27, 2018 12:22pm ET 40,235 volume. .40. No
BooDog
08/27/2018 12:29:21 PM
48063
Sideways with psar support. Bllingers still
BooDog
08/27/2018 12:07:31 PM
48062
The Trump pump presses onward. Hope Leo is
(2)
Squar
08/27/2018 11:41:16 AM
48061
Bunny says that at a price of .75 Leo will be a
scottyincuffs
08/27/2018 11:02:29 AM
48060
Zero....
(3)
bejamin
08/26/2018 11:49:29 AM
48059
Reminder on using the ignore button: click on the
(1)
Drano
08/26/2018 12:06:25 AM
48058
Happy to share. It's ok to be a bull without
(5)
Squar
08/25/2018 11:59:48 PM
48057
Its so nice of squotty to share his knowledge
(2)
someconcerns
08/25/2018 10:54:22 PM
48056
Obviously it doesn't take long for the identities
(6)
Drano
08/25/2018 5:10:12 PM
48055
Obviously if the stock price makes it's way to
(4)
Squar
08/25/2018 12:33:10 PM
48054
imo everything NR does is % based .. my figure
(3)
4kids
08/25/2018 9:43:37 AM
48053
We do seem to have a lot of great things that
(4)
petemantx
08/25/2018 9:20:06 AM
48052
I made the case a while ago about P and B-OM not
Trading Pro Broker
08/25/2018 9:12:30 AM
48051
So the legal short is on the rise in spite of
AlanC
08/25/2018 9:08:45 AM
48050
I hope we are all right!
Commando911
08/25/2018 8:21:36 AM
48049
I fully agree with you Peter Very wise comments
aragon1959
08/24/2018 7:33:00 PM
48048
I think the case for Prurisol for psoriasis is an
(5)
petemantx
08/24/2018 7:13:16 PM
48047
I am faithful long IPIX investor and I believe
(2)
aragon1959
08/24/2018 6:05:09 PM
48046
latest IPIX *legal* out .. ;) a slight increase
(3)
4kids
08/24/2018 5:57:49 PM
48045
Uplisting takes this to new all time highs.
(6)
Dynabolic
08/24/2018 4:14:14 PM
48044
Well...assuming we Get a drug into phase 3. (1yr)
(4)
Squar
08/24/2018 2:57:32 PM
48043
2 Billion looks like a low estimate for 1 years
Jimmyboy
08/24/2018 1:35:20 PM
48042
It is oh so obvious. It's sickening.
(1)
grotty
08/24/2018 12:52:38 PM
48041
A quote from Leo " Big Pharma knows that we know
scottyincuffs
08/24/2018 12:45:16 PM
48040
I'm getting emails and PMs telling me that the
(6)
Drano
08/24/2018 12:25:54 PM
48039
Easy there Scotty. $13 is about $2 billion.
(1)
Squar
08/24/2018 12:15:49 PM
48038
Yes, a soft basher in the Phcotty mode trying to
(3)
someconcerns
08/24/2018 12:13:50 PM
48037
Only an IHUB basher would post those silly butt
(3)
scottyincuffs
08/24/2018 12:01:45 PM
Newer
Older
Recent Articles
Insider Trading at Motorola Solutions: CEO's Significant Sale
National Press Club Urges Withdrawal of Journalist Visa Changes
TrialHub Triumphs at DPHARM Idol Disrupt by Emphasizing Patient-Centric Research
Innovative Condom Packaging Designed to Enhance Intimacy
New Leadership at American Forests: Hilary Franz Takes Charge
Exploring Immutable Azopt: The Future of AI Trading Platforms
Precision Cell Systems Strengthens Market Position with Acquisitions
Lucid Group Stock: Insights on Recent Trends and Future Moves
Enhancing Patient Care Through Innovative Identity Verification
Investing in First Citizens BancShares: A Decade of Growth
Teamsters Local 210 Restart Negotiations with Strong Support
BulletinHealthcare Partners with AMCP for Enhanced Media Outreach
Exploring Quantum Generative Networks for Machine Learning Enhancements
Innovative Collaboration Unveils Mighty Hornet IV Attack Drone
Aker-Nscale and Microsoft Forge Landmark AI Infrastructure Deal
Investors Alert: Luminar Technologies Faces Lawsuit Risk
Investigation of RCI Hospitality Holdings Sparks Investor Concerns
Analyzing NVIDIA and Competitors in the Semiconductor Space
Urban Outfitters P/E Ratio Insights: A Closer Look
Microsoft's Competitive Edge: Analyzing Key Financial Metrics
Comparative Analysis of Meta Platforms with Industry Rivals
California Housing Market 2026: Sales and Pricing Trends Ahead
Exploring the Latest Trends in American Real Estate Market
Rubicon Fund II Expands Multifamily Investments Amid Growth
NKSCX Launches Advanced Wealth Management for Digital Assets
ACADIA Pharmaceuticals Insider Sale: Key Takeaways and Impact
Unlocking the Future of Finance with MANTRA's Innovations
Walmart's CTO Sells $3.1M in Stock: Implications and Insights
Leadership Changes at Kering: Francesca Bellettini Takes Charge
Insights on Global Partners Insider Selling and Financial Trends
Michelin Shares Buyback: Key Details and Strategies Revealed
Inside Look: Daktronics Director Invests in Growth
Compagnie de l'Odet Financial Performance Overview - H1 2025
Insider Insights: Michael Whitehead Sells Lincoln Electric Shares
Nyrstar NV Shares Insights from First Half 2025 Performance
Understanding Dorian LPG's Recent Insider Trading Activity
Upcoming RIKB 42 0217 Treasury Bond Auction Insight
Confidence Shines as Insider Lance D. Bultena Invests in DAKT
Exor Reports Strong H1 2025 Performance with Strategic Gains
Bolloré's Performance Review for First Half of 2025
Daktronics Insider Purchase Signals Confidence in Stock Growth
Examining Recent Insider Trading: John P. Friel's Sale at Daktronics
Sidetrade Achieves Record Revenue and Profitability Milestones
Shereta D. Williams Shows Confidence in Daktronics with Stock Buy
Jose-Marie Griffiths Invests $84K in Daktronics Shares
Sola Security Revolutionizes Cybersecurity with Innovative AI Tools
Neil Glat's Strategic Insider Purchase: A Closer Look
RightRev Enhances Revenue Recognition Solutions with Salesforce
J.Crew Revitalizes Fashion with the Rollneck™ Sweater
Insider Selling Sparks Interest: Credo Technology Group Update